🔎 Trials Near Me

Akèy › Maladi Crohn › Ohio › Parma

Etid klinik pou Maladi Crohn nan Parma, OH

8 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Parma (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2
  • Gastro Intestinal Research Institute of Northern Ohio /ID# 283860, Westlake · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07697456

Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease

Ap rekriteVolontè an sante akeyi
  • UH Westlake Health Center, Westlake · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07852273

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Ap rekriteFaz 4
  • NorthShore Gastroenterology Research, LLC, Westlake · 11 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328

Non-nutritive Sweeteners in Inflammatory Bowel Disease

Ap rekriteVolontè an sante akeyi
  • UH Westlake Health Center, Westlake · 11 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT07769437

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Ap rekriteFaz 3
  • Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake · 11 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • North Shore Gastroenterology Research-Site Number: 8400130, Westlake · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • North Shore Gastroenterology Research-Site Number: 8400130, Westlake · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Ap rekriteFaz 4
  • Gastro Intestinal Research Institute of Northern Ohio, LLC., Westlake · 11 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754

Etid Maladi Crohn nan lòt vil

Lòt etid nan Parma

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.